iCAD, INC. (NASDAQ:ICAD)
CAPS Rating:
The Company designs, develops, manufactures and markets Computer-Aided Detection solutions that enable healthcare professionals to serve patients by identifying pathologies and pinpointing cancer earlier.
RSS Headlines
Fool UK
Recs
with no cash reserves,a dwindling net assets and othe financials, this dosen't look like a smart play to me. the company is still young and seems to be doing some things right,but has a long way to go before it would be a player. i see it under performing in the near term.
Your comment displays a lack of understanding of the company. This is not a young company by any means. It went public almost 20 years ago.